PTC Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PTCT | IONS | DSGN | PYC.AX | BBIO | DNLI | |
|---|---|---|---|---|---|---|
| Market cap | 5.76B | 6.67B | 665.24M | 1.90B | 15.17B | 3.35B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | 28.4 | -35.0 | -6.6 | -23.0 | -225.0 | -8.9 |
| Price/book | -30.1 | 15.1 | 3.0 | 2.7 | -5.9 | 3.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −5.09% | −45.82% | +54.73% | +58.80% | +24.17% | +45.45% |
| Today | +1.25% | −0.67% | +2.80% | +4.32% | +5.21% | +7.76% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All PTCT news ›PTC Therapeutics Raises 2026 Outlook as Q3 Revenue Hits $358 Million
Chief Executive Officer Matthew B. Klein said the company delivered “another strong quarter of record product revenue led by the continued momentum of the Sephience launch,” and said the performance has PTC on track to achieve its cash…
PTC Therapeutics (PTCT) Gets a Hold from RBC Capital
In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on PTC Therapeutics, with a price target of $85.00. Abrahams covers the Healthcare sector, focusing on stocks such as Regeneron, Neurocrine, and Biogen.…
PTC sees $960M-$990M 2026 product revenue as Sephience expands and ST-920 filing targets Q4 2026
PTC Therapeutics Q3 2026 earnings: raised revenue guidance, Sephience growth, and ST-920 launch plans. Earnings Call Insights: PTC Therapeutics (PTCT) Q3 2026 - "I'm pleased to share the results of another quarter of record product revenue…
Pelthos Therapeutics stock sinks after Castle Creek merger deal
Pelthos shares sank 35% after its Castle Creek merger deal. - Pelthos Therapeutics (PTHS) shares fell ~35% to $10.79 on Friday after the company agreed to merge with Castle Creek Biosciences (CCBS), expanding its portfolio into cell and…
PTC Therapeutics, Inc. (PTCT) Q3 2026 Earnings Call Transcript
PTC Therapeutics, Inc. (PTCT) Q3 2026 Earnings Call October 29, 2026 4:30 PM EDT Ellen Cavaleri - Head of Investor RelationsMatthew Klein - CEO & DirectorEric Pauwels - Chief Business OfficerPierre Gravier - Chief Financial Officer Ladies…
More from 1 other outlet
PTC Therapeutics, Inc. completed the acquisition of ST-920 ? a BLA-stage one-time administered AAV gene therapy from Sangamo Therapeutics, Inc. (OTCPK: SGMO.Q).
PTC Therapeutics, Inc. proposed to acquire ST-920 ? a BLA-stage one-time administered AAV gene therapy from Sangamo Therapeutics, Inc. for approximately $210 million on August 12, 2026. A cash... (NasdaqGS:PTCT) proposed to acquire ST-920…
Transcript : PTC Therapeutics, Inc. - Special Call
Presentation Operator MessageOperator Ladies and gentlemen, thank you for standing by. Welcome to PTC Therapeutics' Fabry Disease Transaction Call. [Operator Instructions] Please be advised that... Transcript : PTC Therapeutics, Inc. -…
PTC Therapeutics, Inc. Updates Earnings Guidance for the Full Year 2026
PTC Therapeutics, Inc. updated earnings guidance for the full year 2026. For the year, expected total revenue increased to $1.29 billion to $1.32 billion, with total product revenue guidance raised to ... PTC Therapeutics, Inc. Updates…
PTC Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, Oct. 29, 2026
/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its third quarter 2026... WARREN, N.J., Oct. 15, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:…
Northern Trust officer proposes $662K share sale
SELLAS Life Sciences Reaches 80th Event in Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia Elong Power Holding Limited (NASDAQ: ELPW) Announces Subsidiary’s Entry into a US$25.5 Million Annual Cooperation Agreement,…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net58
- marketscreener.com9
- defenseworld.net3
- seekingalpha.com3
- tradingview.com3
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 89 articles, not a forecast.